PDSB 10-Q: SEC filing

PDS Biotechnology

Filed with the SEC on · accession 0001140361-26-043844

PDSB filed a 10-Q (quarterly report) with the SEC on Nov 16, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved +5.9% by the first close after the filing.

Summary of the filing

PDS Biotechnology filed its quarterly 10-Q for the period ended September 30, 2026, reporting a net loss and a decline in cash and cash equivalents to $15.2 million from $26.7 million at year-end 2025, with no debt outstanding.

Key details

Cash and cash equivalents as of September 30, 2026$15.2M
Cash and cash equivalents as of December 31, 2025$26.7M
Total assets as of September 30, 2026$18.6M
Total liabilities as of September 30, 2026$5.1M
Accumulated deficit as of September 30, 2026$241.3M
Total stockholders' equity as of September 30, 2026$13.5M
RegistrantPDS Biotechnology Corporation

How PDSB stock reacted

Close before

$0.87

Nov 13, 2026

First close after

+5.90%

$0.92

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for PDSB, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for PDSB?

Click here

Frequently asked questions

What did PDSB file with the SEC on Nov 16, 2026?

PDSB filed a 10-Q (SEC filing). PDS Biotechnology filed its quarterly 10-Q for the period ended September 30, 2026, reporting a net loss and a decline in cash and cash equivalents to $15.2 million from $26.7 million at year-end 2025, with no debt outstanding.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did PDSB stock react to this filing?

PDSB closed at $0.87 before the filing and $0.92 on Nov 16, 2026 (+5.90%).

Other PDSB SEC filings

Get alerts when PDSB files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days